ASCO20: What are the key clinical messages from the SPARTAN study?

Eric Small | ASCO20 Virtual | Onkologi /hematologi | Juni 3, 2020

Speaker: Eric Small

In this MEDtalk, Eric J. Small talks about to which extent patients with non-metastatic castration-resistant prostate cancer achieve metastasis-free survival and whether it is possible to delay the time until chemotherapy, as well as the impact of treatment on survival.